Insider trades
Mark Hopman, Chief Officer of Beta Bionics BBNX, has filed 0 purchases and 14 sales on the open market. Over the past 12 months that comes to a net sale of $192.2K. The latest trade was on 06/24.
Mark Hopman
Chief Commercial Officer
- Company
- Beta Bionics BBNX
- First filing
- 25/01/31
- Trades
- 33 trades
- Buys / sales
- 0 / 14
- 12-month net buying
- −$192.2K
- Last trade
- 06/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Beta BionicsBBNX | Open-market sale10b5-1 plan | 06/24 | 06/25 | 1,258 sh | $15.01 | $18,882.58 | −1.0% |
Beta BionicsBBNX | Open-market sale10b5-1 plan | 06/04 | 06/05 | 275 sh | $12.31 | $3,385.25 | −0.2% |
Beta BionicsBBNX | Open-market sale | 06/02 | 06/03 | 5,329 sh | $12.61 | $67,198.69 | −3.9% |
BBNX | Open-market sale10b5-1 plan | 25/12/02–25/12/04 | 03/16 | 2,917 sh2 trades | $30.27avg. | $88,305.3 | −2.1% |
Beta BionicsBBNX | Open-market sale10b5-1 plan | 03/04 | 03/05 | 353 sh | $11.57 | $4,084.21 | −0.3% |
Beta BionicsBBNX | Open-market sale | 03/02 | 03/03 | 834 sh | $12.36 | $10,308.24 | −0.6% |
BBNX | Open-market sale10b5-1 plan | 25/09/04–25/09/05 | 25/09/08 | 18,229 sh2 trades | $20.34avg. | $370,765.62 | −36.9% |
Beta BionicsBBNX | Open-market sale | 25/09/02 | 25/09/04 | 848 sh | $18.86 | $15,993.28 | −2.5% |
Beta BionicsBBNX | Open-market sale10b5-1 plan | 25/08/19 | 25/08/20 | 16,158 sh | $16.61 | $268,384.38 | −32.1% |
BBNX | Open-market sale | 25/06/02 | 25/06/04 | 868 sh3 trades | $17.89avg. | $15,530.3 | −2.5% |